Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Boyd Group Services price target raised to C$275 from C$255 at TD Securities » 12:59
08/16/21
08/16
12:59
08/16/21
12:59
BYDGF

Boyd Group Services

$193.18 /

+ (+0.00%)

TD Securities analyst…

TD Securities analyst Daryl Young raised the firm's price target on Boyd Group Services to C$275 from C$255 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
BYDGF Boyd Group Services
$193.18 /

+ (+0.00%)

08/12/21 Raymond James
Boyd Group Services price target raised to C$262 from C$240 at Raymond James
08/12/21 Stifel
Boyd Group Services downgraded to Hold from Buy at Stifel
08/12/21 National Bank
Boyd Group Services downgraded to Sector Perform from Outperform at National Bank
08/04/21 Desjardins
Boyd Group Services price target raised to C$260 from C$240 at Desjardins
Recommendations
Boyd Group Services price target raised to C$262 from C$240 at Raymond James » 12:32
08/12/21
08/12
12:32
08/12/21
12:32
BYDGF

Boyd Group Services

$194.23 /

-1.59283 (-0.81%)

Raymond James analyst…

Raymond James analyst Steve Hansen raised the firm's price target on Boyd Group Services to C$262 from C$240 and keeps an Outperform rating on the shares.

ShowHide Related Items >><<
BYDGF Boyd Group Services
$194.23 /

-1.59283 (-0.81%)

08/12/21 Stifel
Boyd Group Services downgraded to Hold from Buy at Stifel
08/12/21 National Bank
Boyd Group Services downgraded to Sector Perform from Outperform at National Bank
08/04/21 Desjardins
Boyd Group Services price target raised to C$260 from C$240 at Desjardins
07/23/21 Scotiabank
Boyd Group Services price target raised to C$265 from C$245 at Scotiabank
Downgrade
Boyd Group Services downgraded to Hold from Buy at Stifel » 08:10
08/12/21
08/12
08:10
08/12/21
08:10
BYDGF

Boyd Group Services

$194.23 /

-1.59283 (-0.81%)

Stifel analyst Maggie…

Stifel analyst Maggie MacDougall downgraded Boyd Group Services to Hold from Buy with an unchanged price target of C$240, citing valuation after what she calls a "good quarter." Though she views Boyd as a "high quality company" with "a considerable long term runway for growth," the stock is presently pricing in about 210 store additions over 2021-22 along with a return of pre-COVID profitability, noted MacDougall.

ShowHide Related Items >><<
BYDGF Boyd Group Services
$194.23 /

-1.59283 (-0.81%)

08/12/21 National Bank
Boyd Group Services downgraded to Sector Perform from Outperform at National Bank
08/04/21 Desjardins
Boyd Group Services price target raised to C$260 from C$240 at Desjardins
07/23/21 Scotiabank
Boyd Group Services price target raised to C$265 from C$245 at Scotiabank
07/22/21 BMO Capital
Boyd Group Services price target raised to C$272 from C$248 at BMO Capital
Downgrade
Boyd Group Services downgraded to Sector Perform from Outperform at National Bank » 05:23
08/12/21
08/12
05:23
08/12/21
05:23
BYDGF

Boyd Group Services

$194.23 /

-1.59283 (-0.81%)

National Bank analyst…

National Bank analyst Zachary Evershed downgraded Boyd Group Services to Sector Perform from Outperform with a price target of C$255, down from C$260, citing a nearly 12% run up in the stock since the company reported Q1 results and a slight increase in his projected net debt estimate.

ShowHide Related Items >><<
BYDGF Boyd Group Services
$194.23 /

-1.59283 (-0.81%)

08/04/21 Desjardins
Boyd Group Services price target raised to C$260 from C$240 at Desjardins
07/23/21 Scotiabank
Boyd Group Services price target raised to C$265 from C$245 at Scotiabank
07/22/21 BMO Capital
Boyd Group Services price target raised to C$272 from C$248 at BMO Capital
05/13/21 CIBC
Boyd Group Services price target lowered to C$260 from C$275 at CIBC
Recommendations
Boyd Group Services price target raised to C$260 from C$240 at Desjardins » 11:30
08/04/21
08/04
11:30
08/04/21
11:30
BYDGF

Boyd Group Services

$194.11 /

-2.49016 (-1.27%)

Desjardins analyst David…

Desjardins analyst David Newman raised the firm's price target on Boyd Group Services to C$260 from C$240 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
BYDGF Boyd Group Services
$194.11 /

-2.49016 (-1.27%)

07/23/21 Scotiabank
Boyd Group Services price target raised to C$265 from C$245 at Scotiabank
07/22/21 BMO Capital
Boyd Group Services price target raised to C$272 from C$248 at BMO Capital
05/13/21 CIBC
Boyd Group Services price target lowered to C$260 from C$275 at CIBC
05/13/21 BMO Capital
Boyd Group Services price target lowered to C$248 from C$263 at BMO Capital
Recommendations
Boyd Group Services price target raised to C$265 from C$245 at Scotiabank » 11:57
07/23/21
07/23
11:57
07/23/21
11:57
BYDGF

Boyd Group Services

$187.86 /

+ (+0.00%)

Scotiabank analyst…

Scotiabank analyst Michael Doumet raised the firm's price target on Boyd Group Services to C$265 from C$245 and keeps an Outperform rating on the shares.

ShowHide Related Items >><<
BYDGF Boyd Group Services
$187.86 /

+ (+0.00%)

07/22/21 BMO Capital
Boyd Group Services price target raised to C$272 from C$248 at BMO Capital
05/13/21 CIBC
Boyd Group Services price target lowered to C$260 from C$275 at CIBC
05/13/21 BMO Capital
Boyd Group Services price target lowered to C$248 from C$263 at BMO Capital
05/13/21 Stifel
Boyd Group Services price target lowered to C$240 from C$250 at Stifel
Recommendations
Boyd Group Services price target raised to C$272 from C$248 at BMO Capital » 11:39
07/22/21
07/22
11:39
07/22/21
11:39
BYDGF

Boyd Group Services

$187.86 /

+5.71955 (+3.14%)

BMO Capital analyst…

BMO Capital analyst Jonathan Lamers raised the firm's price target on Boyd Group Services to C$272 from C$248 and keeps an Outperform rating on the shares.

ShowHide Related Items >><<
BYDGF Boyd Group Services
$187.86 /

+5.71955 (+3.14%)

05/13/21 CIBC
Boyd Group Services price target lowered to C$260 from C$275 at CIBC
05/13/21 BMO Capital
Boyd Group Services price target lowered to C$248 from C$263 at BMO Capital
05/13/21 Stifel
Boyd Group Services price target lowered to C$240 from C$250 at Stifel
05/13/21 National Bank
Boyd Group Services price target lowered to C$260 from C$265 at National Bank
Over a quarter ago
Conference/Events
RBC Capital Markets to hold a virtual conference » 04:55
05/19/21
05/19
04:55
05/19/21
04:55
AEGXF

Aecon Group

$15.09 /

+ (+0.00%)

, BYDGF

Boyd Group Services

$169.85 /

+ (+0.00%)

, CNI

Canadian National

$108.42 /

-0.09 (-0.08%)

, CP

Canadian Pacific

$77.05 /

-0.75 (-0.96%)

, GBT

Global Blood Therapeutics

$37.32 /

+0.97 (+2.67%)

, GDRX

GoodRx

$30.22 /

-0.18 (-0.59%)

, GILD

Gilead

$68.84 /

-0.2498 (-0.36%)

, IONS

Ionis Pharmaceuticals

$36.89 /

-0.425 (-1.14%)

, MRETF

Martinrea

$10.90 /

-0.08 (-0.73%)

Automotive, Industrials…

Automotive, Industrials & Transportation Virtual Conference will be held on May 17-19.

ShowHide Related Items >><<
MRETF Martinrea
$10.90 /

-0.08 (-0.73%)

IONS Ionis Pharmaceuticals
$36.89 /

-0.425 (-1.14%)

GILD Gilead
$68.84 /

-0.2498 (-0.36%)

GDRX GoodRx
$30.22 /

-0.18 (-0.59%)

GBT Global Blood Therapeutics
$37.32 /

+0.97 (+2.67%)

CP Canadian Pacific
$77.05 /

-0.75 (-0.96%)

CNI Canadian National
$108.42 /

-0.09 (-0.08%)

AEGXF Aecon Group
$15.09 /

+ (+0.00%)

AEGXF Aecon Group
$15.09 /

+ (+0.00%)

04/26/21 BMO Capital
Aecon Group price target lowered to C$19 from C$20 at BMO Capital
04/26/21 Canaccord
Aecon Group price target raised to C$23 from C$21 at Canaccord
03/02/21 Desjardins
Aecon Group price target raised to C$23 from C$20 at Desjardins
03/02/21 TD Securities
Aecon Group price target raised to C$22 from C$19 at TD Securities
BYDGF Boyd Group Services
$169.85 /

+ (+0.00%)

05/13/21 CIBC
Boyd Group Services price target lowered to C$260 from C$275 at CIBC
05/13/21 BMO Capital
Boyd Group Services price target lowered to C$248 from C$263 at BMO Capital
05/13/21 Stifel
Boyd Group Services price target lowered to C$240 from C$250 at Stifel
05/13/21 National Bank
Boyd Group Services price target lowered to C$260 from C$265 at National Bank
CNI Canadian National
$108.42 /

-0.09 (-0.08%)

05/18/21 Vertical Research
Canadian National upgraded to Buy from Hold at Vertical Research
05/14/21 Stephens
Canadian rail that loses KCS likely to pursue an Eastern rail, says Stephens
05/14/21 Citi
Citi sees Canadian National, Kansas City Southern deal as most likely outcome
04/27/21 CIBC
Canadian National price target lowered to C$146 from C$148 at CIBC
CP Canadian Pacific
$77.05 /

-0.75 (-0.96%)

05/18/21
Fly Intel: Top five analyst downgrades
05/18/21 National Bank
Canadian Pacific downgraded to Sector Perform from Outperform at National Bank
05/17/21 Raymond James
Canadian Pacific price target updated to reflect 5-for-1 split at Raymond James
05/17/21 Scotiabank
Canadian Pacific price target updated to reflect 5-for-1 split at Scotiabank
GBT Global Blood Therapeutics
$37.32 /

+0.97 (+2.67%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
GDRX GoodRx
$30.22 /

-0.18 (-0.59%)

05/18/21 Credit Suisse
GoodRx price target lowered to $45 from $50 at Credit Suisse
05/14/21 RBC Capital
GoodRx price target lowered to $50 from $56 at RBC Capital
05/14/21 Barclays
GoodRx price target lowered to $33 from $43 at Barclays
05/14/21 Citi
GoodRx price target lowered to $53 from $70 at Citi
GILD Gilead
$68.84 /

-0.2498 (-0.36%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
IONS Ionis Pharmaceuticals
$36.89 /

-0.425 (-1.14%)

05/07/21 UBS
Ionis Pharmaceuticals upgraded to Neutral from Sell at UBS
03/29/21 Piper Sandler
Ionis' Phase 2 data for PKK-LRx 'impressive' at face value, says Piper Sandler
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
MRETF Martinrea
$10.90 /

-0.08 (-0.73%)

04/30/21 TD Securities
Martinrea price target lowered to C$18 from C$18.50 at TD Securities
03/05/21 BMO Capital
Martinrea price target raised to C$17 from C$16 at BMO Capital
03/05/21 Scotiabank
Martinrea price target lowered to C$18.50 from C$19.50 at Scotiabank
03/05/21 TD Securities
Martinrea downgraded to Hold from Buy at TD Securities
IONS Ionis Pharmaceuticals
$36.89 /

-0.425 (-1.14%)

GILD Gilead
$68.84 /

-0.2498 (-0.36%)

GDRX GoodRx
$30.22 /

-0.18 (-0.59%)

GBT Global Blood Therapeutics
$37.32 /

+0.97 (+2.67%)

CP Canadian Pacific
$77.05 /

-0.75 (-0.96%)

CNI Canadian National
$108.42 /

-0.09 (-0.08%)

  • 23
    Sep
GILD Gilead
$68.84 /

-0.2498 (-0.36%)

GDRX GoodRx
$30.22 /

-0.18 (-0.59%)

CP Canadian Pacific
$77.05 /

-0.75 (-0.96%)

CNI Canadian National
$108.42 /

-0.09 (-0.08%)

IONS Ionis Pharmaceuticals
$36.89 /

-0.425 (-1.14%)

GILD Gilead
$68.84 /

-0.2498 (-0.36%)

GDRX GoodRx
$30.22 /

-0.18 (-0.59%)

GBT Global Blood Therapeutics
$37.32 /

+0.97 (+2.67%)

CNI Canadian National
$108.42 /

-0.09 (-0.08%)

IONS Ionis Pharmaceuticals
$36.89 /

-0.425 (-1.14%)

GILD Gilead
$68.84 /

-0.2498 (-0.36%)

GDRX GoodRx
$30.22 /

-0.18 (-0.59%)

CP Canadian Pacific
$77.05 /

-0.75 (-0.96%)

Conference/Events
RBC Capital Markets to hold a virtual conference » 04:55
05/18/21
05/18
04:55
05/18/21
04:55
AEGXF

Aecon Group

$15.09 /

-0.11 (-0.72%)

, BYDGF

Boyd Group Services

$169.85 /

-6.98873 (-3.95%)

, CNI

Canadian National

$108.51 /

+1.09 (+1.01%)

, CP

Canadian Pacific

$77.80 /

-2.125 (-2.66%)

, GBT

Global Blood Therapeutics

$36.38 /

+0.19 (+0.53%)

, GDRX

GoodRx

$30.40 /

-0.59 (-1.90%)

, GILD

Gilead

$69.09 /

+0.54 (+0.79%)

, IONS

Ionis Pharmaceuticals

$37.34 /

-0.9 (-2.35%)

, MRETF

Martinrea

$10.98 /

-0.08 (-0.72%)

Automotive, Industrials…

Automotive, Industrials & Transportation Virtual Conference will be held on May 17-19.

ShowHide Related Items >><<
MRETF Martinrea
$10.98 /

-0.08 (-0.72%)

IONS Ionis Pharmaceuticals
$37.34 /

-0.9 (-2.35%)

GILD Gilead
$69.09 /

+0.54 (+0.79%)

GDRX GoodRx
$30.40 /

-0.59 (-1.90%)

GBT Global Blood Therapeutics
$36.38 /

+0.19 (+0.53%)

CP Canadian Pacific
$77.80 /

-2.125 (-2.66%)

CNI Canadian National
$108.51 /

+1.09 (+1.01%)

AEGXF Aecon Group
$15.09 /

-0.11 (-0.72%)

AEGXF Aecon Group
$15.09 /

-0.11 (-0.72%)

04/26/21 BMO Capital
Aecon Group price target lowered to C$19 from C$20 at BMO Capital
04/26/21 Canaccord
Aecon Group price target raised to C$23 from C$21 at Canaccord
03/02/21 Desjardins
Aecon Group price target raised to C$23 from C$20 at Desjardins
03/02/21 TD Securities
Aecon Group price target raised to C$22 from C$19 at TD Securities
BYDGF Boyd Group Services
$169.85 /

-6.98873 (-3.95%)

05/13/21 CIBC
Boyd Group Services price target lowered to C$260 from C$275 at CIBC
05/13/21 BMO Capital
Boyd Group Services price target lowered to C$248 from C$263 at BMO Capital
05/13/21 Stifel
Boyd Group Services price target lowered to C$240 from C$250 at Stifel
05/13/21 National Bank
Boyd Group Services price target lowered to C$260 from C$265 at National Bank
CNI Canadian National
$108.51 /

+1.09 (+1.01%)

05/14/21 Stephens
Canadian rail that loses KCS likely to pursue an Eastern rail, says Stephens
05/14/21 Citi
Citi sees Canadian National, Kansas City Southern deal as most likely outcome
04/27/21 CIBC
Canadian National price target lowered to C$146 from C$148 at CIBC
04/27/21 Wells Fargo
Canadian National price target raised to $120 from $113 at Wells Fargo
CP Canadian Pacific
$77.80 /

-2.125 (-2.66%)

05/17/21 Raymond James
Canadian Pacific price target updated to reflect 5-for-1 split at Raymond James
05/17/21 Scotiabank
Canadian Pacific price target updated to reflect 5-for-1 split at Scotiabank
GBT Global Blood Therapeutics
$36.38 /

+0.19 (+0.53%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
GDRX GoodRx
$30.40 /

-0.59 (-1.90%)

05/14/21 RBC Capital
GoodRx price target lowered to $50 from $56 at RBC Capital
05/14/21 Barclays
GoodRx price target lowered to $33 from $43 at Barclays
05/14/21 Citi
GoodRx price target lowered to $53 from $70 at Citi
05/12/21 SVB Leerink
GoodRx moat still intact as Amazon Pharmacy push continues, says SVB Leerink
GILD Gilead
$69.09 /

+0.54 (+0.79%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
IONS Ionis Pharmaceuticals
$37.34 /

-0.9 (-2.35%)

05/07/21 UBS
Ionis Pharmaceuticals upgraded to Neutral from Sell at UBS
03/29/21 Piper Sandler
Ionis' Phase 2 data for PKK-LRx 'impressive' at face value, says Piper Sandler
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
MRETF Martinrea
$10.98 /

-0.08 (-0.72%)

04/30/21 TD Securities
Martinrea price target lowered to C$18 from C$18.50 at TD Securities
03/05/21 BMO Capital
Martinrea price target raised to C$17 from C$16 at BMO Capital
03/05/21 Scotiabank
Martinrea price target lowered to C$18.50 from C$19.50 at Scotiabank
03/05/21 TD Securities
Martinrea downgraded to Hold from Buy at TD Securities
IONS Ionis Pharmaceuticals
$37.34 /

-0.9 (-2.35%)

GILD Gilead
$69.09 /

+0.54 (+0.79%)

GDRX GoodRx
$30.40 /

-0.59 (-1.90%)

GBT Global Blood Therapeutics
$36.38 /

+0.19 (+0.53%)

CP Canadian Pacific
$77.80 /

-2.125 (-2.66%)

CNI Canadian National
$108.51 /

+1.09 (+1.01%)

  • 23
    Sep
GILD Gilead
$69.09 /

+0.54 (+0.79%)

GDRX GoodRx
$30.40 /

-0.59 (-1.90%)

CP Canadian Pacific
$77.80 /

-2.125 (-2.66%)

CNI Canadian National
$108.51 /

+1.09 (+1.01%)

IONS Ionis Pharmaceuticals
$37.34 /

-0.9 (-2.35%)

GILD Gilead
$69.09 /

+0.54 (+0.79%)

GDRX GoodRx
$30.40 /

-0.59 (-1.90%)

GBT Global Blood Therapeutics
$36.38 /

+0.19 (+0.53%)

CNI Canadian National
$108.51 /

+1.09 (+1.01%)

IONS Ionis Pharmaceuticals
$37.34 /

-0.9 (-2.35%)

GILD Gilead
$69.09 /

+0.54 (+0.79%)

GDRX GoodRx
$30.40 /

-0.59 (-1.90%)

CP Canadian Pacific
$77.80 /

-2.125 (-2.66%)

Conference/Events
RBC Capital Markets to hold a virtual conference » 09:52
05/17/21
05/17
09:52
05/17/21
09:52
AEGXF

Aecon Group

$15.20 /

+0.34 (+2.29%)

, BYDGF

Boyd Group Services

$176.83 /

-5.51677 (-3.03%)

, CNI

Canadian National

$107.47 /

+0.05 (+0.05%)

, CP

Canadian Pacific

$79.99 /

+0.07 (+0.09%)

, GBT

Global Blood Therapeutics

$36.19 /

+ (+0.00%)

, GDRX

GoodRx

$30.08 /

-0.91 (-2.94%)

, GILD

Gilead

$68.98 /

+0.43 (+0.63%)

, IONS

Ionis Pharmaceuticals

$38.15 /

-0.09 (-0.24%)

, MRETF

Martinrea

$11.06 /

+0.27 (+2.50%)

Automotive, Industrials…

Automotive, Industrials & Transportation Virtual Conference will be held on May 17-19.

ShowHide Related Items >><<
MRETF Martinrea
$11.06 /

+0.27 (+2.50%)

IONS Ionis Pharmaceuticals
$38.15 /

-0.09 (-0.24%)

GILD Gilead
$68.98 /

+0.43 (+0.63%)

GDRX GoodRx
$30.08 /

-0.91 (-2.94%)

GBT Global Blood Therapeutics
$36.19 /

+ (+0.00%)

CNI Canadian National
$107.47 /

+0.05 (+0.05%)

AEGXF Aecon Group
$15.20 /

+0.34 (+2.29%)

AEGXF Aecon Group
$15.20 /

+0.34 (+2.29%)

04/26/21 BMO Capital
Aecon Group price target lowered to C$19 from C$20 at BMO Capital
04/26/21 Canaccord
Aecon Group price target raised to C$23 from C$21 at Canaccord
03/02/21 Desjardins
Aecon Group price target raised to C$23 from C$20 at Desjardins
03/02/21 TD Securities
Aecon Group price target raised to C$22 from C$19 at TD Securities
BYDGF Boyd Group Services
$176.83 /

-5.51677 (-3.03%)

05/13/21 CIBC
Boyd Group Services price target lowered to C$260 from C$275 at CIBC
05/13/21 BMO Capital
Boyd Group Services price target lowered to C$248 from C$263 at BMO Capital
05/13/21 Stifel
Boyd Group Services price target lowered to C$240 from C$250 at Stifel
05/13/21 National Bank
Boyd Group Services price target lowered to C$260 from C$265 at National Bank
CNI Canadian National
$107.47 /

+0.05 (+0.05%)

05/14/21 Stephens
Canadian rail that loses KCS likely to pursue an Eastern rail, says Stephens
05/14/21 Citi
Citi sees Canadian National, Kansas City Southern deal as most likely outcome
04/27/21 CIBC
Canadian National price target lowered to C$146 from C$148 at CIBC
04/27/21 Wells Fargo
Canadian National price target raised to $120 from $113 at Wells Fargo
CP Canadian Pacific
$79.99 /

+0.07 (+0.09%)

04/26/21 Deutsche Bank
Canadian Pacific price target raised to $405 from $368 at Deutsche Bank
04/26/21 Susquehanna
Canadian Pacific will have to raise bid to win KSU war, says Susquehanna
GBT Global Blood Therapeutics
$36.19 /

+ (+0.00%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
GDRX GoodRx
$30.08 /

-0.91 (-2.94%)

05/14/21 RBC Capital
GoodRx price target lowered to $50 from $56 at RBC Capital
05/14/21 Barclays
GoodRx price target lowered to $33 from $43 at Barclays
05/14/21 Citi
GoodRx price target lowered to $53 from $70 at Citi
05/12/21 SVB Leerink
GoodRx moat still intact as Amazon Pharmacy push continues, says SVB Leerink
GILD Gilead
$68.98 /

+0.43 (+0.63%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
IONS Ionis Pharmaceuticals
$38.15 /

-0.09 (-0.24%)

05/07/21 UBS
Ionis Pharmaceuticals upgraded to Neutral from Sell at UBS
03/29/21 Piper Sandler
Ionis' Phase 2 data for PKK-LRx 'impressive' at face value, says Piper Sandler
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
MRETF Martinrea
$11.06 /

+0.27 (+2.50%)

04/30/21 TD Securities
Martinrea price target lowered to C$18 from C$18.50 at TD Securities
03/05/21 BMO Capital
Martinrea price target raised to C$17 from C$16 at BMO Capital
03/05/21 Scotiabank
Martinrea price target lowered to C$18.50 from C$19.50 at Scotiabank
03/05/21 TD Securities
Martinrea downgraded to Hold from Buy at TD Securities
IONS Ionis Pharmaceuticals
$38.15 /

-0.09 (-0.24%)

GILD Gilead
$68.98 /

+0.43 (+0.63%)

GDRX GoodRx
$30.08 /

-0.91 (-2.94%)

GBT Global Blood Therapeutics
$36.19 /

+ (+0.00%)

CP Canadian Pacific
$79.99 /

+0.07 (+0.09%)

CNI Canadian National
$107.47 /

+0.05 (+0.05%)

  • 23
    Sep
GILD Gilead
$68.98 /

+0.43 (+0.63%)

GDRX GoodRx
$30.08 /

-0.91 (-2.94%)

CP Canadian Pacific
$79.99 /

+0.07 (+0.09%)

CNI Canadian National
$107.47 /

+0.05 (+0.05%)

IONS Ionis Pharmaceuticals
$38.15 /

-0.09 (-0.24%)

GILD Gilead
$68.98 /

+0.43 (+0.63%)

GDRX GoodRx
$30.08 /

-0.91 (-2.94%)

GBT Global Blood Therapeutics
$36.19 /

+ (+0.00%)

CNI Canadian National
$107.47 /

+0.05 (+0.05%)

IONS Ionis Pharmaceuticals
$38.15 /

-0.09 (-0.24%)

GILD Gilead
$68.98 /

+0.43 (+0.63%)

GDRX GoodRx
$30.08 /

-0.91 (-2.94%)

CP Canadian Pacific
$79.99 /

+0.07 (+0.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.